Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[68Ga]Ga-FAPI Total Body PET/CT for Improving Diagnostic Sensitivity and Preoperative Staging in Gastroesophageal Cancer and Pancreatic Cancer

NCT07629609 is registered in ClinicalTrials.gov with Barbara Malene Fischer as lead sponsor.

NCT NCT07629609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07629609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[68Ga]Ga-FAPI Total Body PET/CT for Improving Diagnostic Sensitivity and Preoperative Staging in Gastroesophageal Cancer and Pancreatic Cancer
Lead sponsor
Barbara Malene Fischer
Phase
Phase 2
Overall status
Recruiting
Start date
January 16, 2024
Completion date
January 31, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal cancer (gc), pancreatic cancer, adult